SET/TAF-I Protein (AA 1-290) (His tag)
SET
Spezies: Human
Wirt: Escherichia coli (E. coli)
Recombinant
Greater than 95 % as determined by SDS-PAGE
ELISA, WB
1 image
-
- Target Alle SET/TAF-I (SET) Proteine anzeigen
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 1-290
- Spezies
- Human
-
Quelle
- Escherichia coli (E. coli)
- Aufreinigungstag / Konjugat
- Dieses SET/TAF-I Protein ist gelabelt mit His tag.
- Applikation
- ELISA, Western Blotting (WB)
- Reinheit
- Greater than 95 % as determined by SDS-PAGE
- Sterilität
- 0.2 μm filtered
-
SET Nuclear Oncogene (SET) (AA 1-277) protein (GST tag)
SET Spezies: Human Wirt: Wheat germ Recombinant ELISA, WB, AP, AA
SET Nuclear Oncogene (SET) (Transcript Variant 2) protein (Myc-DYKDDDDK Tag)SET Spezies: Human Wirt: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
- Buffer
- Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
- Haltbarkeit
- 12 months
-
- Target
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
- Andere Bezeichnung
- SET (SET Produkte)
- Hintergrund
- 2PP2A, HLA DR associated protein II, HLA-DR-associated protein II, I 2PP2A, I-2PP2A, I2PP2A, IGAAD, Inhibitor of granzyme A activated DNase, Inhibitor of granzyme A-activated DNase, Inhibitor of GzmA-activated DNase, inhibitor-2 of protein phosphatase-2A, IPP2A2
- Molekulargewicht
- 31.8 kDa
- UniProt
- Q01105
- Pathways
- Apoptose
-
Sie sind hier:
